Australia outlines roles and duties of IVD sponsors and manufacturers
This article was originally published in RAJ Devices
Executive Summary
Australia's Therapeutic Goods Administration has issued more details on the conformity assessment process under its new in vitro diagnostics regulations that came into force in July last year1-3. Specifically, the TGA has published documents distinguishing between the responsibilities and obligations of IVD sponsors and manufacturers under the new framework.
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.